← Back to headlines
Teva and Medincell Receive FDA Review for Long-Acting Antipsychotic
Teva and Medincell have been granted FDA review for their long-acting antipsychotic drug, marking a step forward in its potential approval.
21 Feb, 14:09 — 21 Feb, 14:09
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
Eli Lilly's Taltz-Zepbound Combo Shows Breakthrough in Psoriasis-Obesity Trial
24m ago
Running — the one exercise that midlife women really need to do - The Times
1h ago
Katseye's Manon Takes Temporary Hiatus for Health Reasons
1h ago
FDA Grants Breakthrough Status to Johnson & Johnson's Cancer Drug for Advanced Head and Neck Cancer
1h ago